...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ... just for whatever reason...
3
Jan 19, 2019 08:31PM
3
Jan 20, 2019 03:12AM

NBB - I not suggesting that ZCC will be listed but may be listed. For the last number of years ZCC's documentation and accounting practices has been at the standards required for a NASDAQ listing. This allowed for that event to happen on a foundation that was put in place well in advance of being necessary if required. DM made this clear a couple of AGM's ago.

tada

1
Jan 20, 2019 07:36PM
Share
New Message
Please login to post a reply